Authors: de Witte, T Suciu, S Verhoef, G Labar, B Archimbaud, E Aul, C Selleslag, D Ferrant, A Wijermans, P Mandelli, F Amadori, S Jehn, U Muus, P Boogaerts, M Zittoun, R Gratwohl, A Zwierzina, H Hagemeijer, A Willemze, R

Citation: T. De Witte et al., Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS, BLOOD, 98(8), 2001, pp. 2326-2331

Authors: de Witte, T Suciu, S Verhoef, G Labar, B Archimbaud, E Aul, C Selleslag, D Ferrant, A Wijermans, P Mandelli, F Amadori, S Jehn, U Muus, P Demuynck, H Dardenne, M Zittoun, R Willemze, R Gratwohl, A Apperley, J

Citation: T. De Witte et al., Intensive chemotherapy followed by stem cell transplantation for the treatment of myelodysplastic syndromes, HEMAT BLOOD, 40, 2001, pp. 649-654

Authors: Jehn, U Bartl, R Dietzfelbinger, H Vehling-Kaiser, U Wolf-Hornung, B Hill, W Heinemann, V

Citation: U. Jehn et al., Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine, ANN HEMATOL, 78(3), 1999, pp. 139-144

Authors: Archimbaud, E Jehn, U Thomas, X De Cataldo, F Fillet, G Belhabri, A Peaud, PY Martin, C Amadori, S Willemze, R

Citation: E. Archimbaud et al., Multicenter randomized phase II trial of idarubicin vs mitoxantrone, combined with VP-16 and cytarabine for induction consolidation therapy, followedby a feasibility study of autologous peripheral blood stem cell transplantation in elderly patients with acute myeloid leukemia, LEUKEMIA, 13(6), 1999, pp. 843-849